Comgest Growth Europe EUR AccRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 16.9 | 26.4 | -16.1 | 20.3 | 3.0 | |
+/-Cat | 2.3 | 9.6 | -0.1 | 6.8 | -0.9 | |
+/-B’mrk | - | - | - | 6.8 | -4.6 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar DM Europe Grt T... |
Key Stats | ||
NAV 10/10/2024 | EUR 45.40 | |
Day Change | -0.36% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | IE0004766675 | |
Fund Size (Mil) 10/10/2024 | EUR 6132.93 | |
Share Class Size (Mil) 10/10/2024 | EUR 1262.89 | |
Max Initial Charge | 4.00% | |
Ongoing Charge 20/02/2023 | 1.55% |
Morningstar Research |
Analyst Report | 11/07/2024 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 24 |
Process | 25 |
Performance | |
Price |
Investment Objective: Comgest Growth Europe EUR Acc |
The investment objective of the Fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 01/11/2009 | ||
Eva Fornadi 30/08/2024 | ||
Click here to see others | ||
Inception Date 15/05/2000 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe EUR Acc | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 9.32 |
ASML Holding NV | Technology | 9.14 |
Essilorluxottica | Healthcare | 5.01 |
Accenture PLC Class A | Technology | 3.91 |
Alcon Inc | Healthcare | 3.90 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe EUR Acc |